Popular Trials
Antioxidant
N-Acetylcysteine for Mitochondrial Disease
Recruiting1 awardPhase 1
New York, New York
This trial will study the effects of N-acetylcysteine (NAC), an anti-oxidant, on brain glutathione levels, cognitive skills, motor skills, and quality of life. 18 participants will take either 1800, 3600 or 5400 mg per day of NAC for 3 months. The goal is to determine a safe and effective dose of NAC for a future clinical trial.
Omega-3 Fatty Acid
Fish Oil + Salsalate for Diabetic Neuropathy
Recruiting1 awardPhase 1 & 2
Iowa City, Iowa
This trial is studying the combination of fish oil and salsalate to see if it is an effective treatment for diabetic peripheral neuropathy (DPN). DPN is a common complication of diabetes that can lead to severe pain, sensory deficits, foot ulcers, and amputations. There is no currently no effective treatment for DPN.
Popular Filters
Trials for Type 2 Diabetes Patients
Online Intervention for Gestational Diabetes Postpartum Care
Recruiting1 award4 criteria
Oakland, California
This trial tests components of an online intervention to help women with GDM get postpartum screening and programs for diabetes prevention. It mixes standard health info with motivational and logistical help. It uses a randomized factorial study design.
Monoclonal Antibodies
Ustekinumab for Type 1 Diabetes
Recruiting0 awardsPhase 2 & 3
Toronto, British Columbia
This trial tests Ustekinumab, a drug used for psoriasis, in adults aged 18-35 with recent-onset type 1 diabetes. The drug aims to protect and regenerate insulin-producing cells by blocking harmful immune cells. This could reduce the need for insulin injections.
Potassium Channel Opener
Diazoxide for Type 2 Diabetes
Recruiting0 awardsPhase 2
Bronx, New York
This trial is testing diazoxide, a drug that activates parts of the brain, on people with type 2 diabetes. The goal is to see if it can help reduce the amount of glucose produced by the liver. By doing so, it may help manage high blood sugar levels in these patients. Diazoxide has been shown to improve blood sugar levels, help with weight loss, and affect certain genes in animal studies.
Trials for Type 1 Diabetes Patients
Monoclonal Antibodies
Ustekinumab for Type 1 Diabetes
Recruiting0 awardsPhase 2 & 3
Toronto, British Columbia
This trial tests Ustekinumab, a drug used for psoriasis, in adults aged 18-35 with recent-onset type 1 diabetes. The drug aims to protect and regenerate insulin-producing cells by blocking harmful immune cells. This could reduce the need for insulin injections.
Potassium Channel Opener
Diazoxide for Type 2 Diabetes
Recruiting0 awardsPhase 2
Bronx, New York
This trial is testing diazoxide, a drug that activates parts of the brain, on people with type 2 diabetes. The goal is to see if it can help reduce the amount of glucose produced by the liver. By doing so, it may help manage high blood sugar levels in these patients. Diazoxide has been shown to improve blood sugar levels, help with weight loss, and affect certain genes in animal studies.
Procedure
Surgical vs. Lifestyle Interventions for Type 2 Diabetes
Recruiting1 award5 criteria
Pittsburgh, Pennsylvania
This trial is being done to compare the effectiveness of two types of bariatric surgery against an intensive lifestyle intervention in promoting weight loss and improvements in Type 2 diabetes in moderately obese patients.
Phase 3 Trials
Insulin
Inhaled Insulin for Gestational Diabetes
Recruiting1 awardPhase 2 & 3
Santa Barbara, California
"This trial will study pregnant women with gestational diabetes to see how two different insulin treatments affect their blood sugar after meals. The women will come to the clinic for two meal sessions where they will use either
Monoclonal Antibodies
Ustekinumab for Type 1 Diabetes
Recruiting0 awardsPhase 2 & 3
Toronto, British Columbia
This trial tests Ustekinumab, a drug used for psoriasis, in adults aged 18-35 with recent-onset type 1 diabetes. The drug aims to protect and regenerate insulin-producing cells by blocking harmful immune cells. This could reduce the need for insulin injections.
Stem Cell Therapy
Stem Cell Educator Therapy for Type 1 Diabetes
Recruiting1 awardPhase 2 & 3
Hackensack, New Jersey
This trial uses Stem Cell Educator (SCE) therapy, which treats a patient's own blood cells with umbilical cord blood stem cells. It targets patients with Type 1 diabetes who need better treatment options. The therapy helps the immune system stop attacking the pancreas by 'educating' the immune cells. Stem Cell Educator therapy has been evaluated through international clinical studies, demonstrating its safety and efficacy in Type 1 diabetes and other autoimmune diseases.
Anti-inflammatory
Colchicine for Cardiovascular Disease in Diabetes
Recruiting1 awardPhase 3
Ottawa, Ontario
This trial tests colchicine to see if it can reduce inflammation in blood vessel plaques in high-risk patients with diabetes or pre-diabetes who recently had a heart attack or stroke. The goal is to prevent future cardiovascular events by reducing plaque inflammation. Colchicine is an ancient drug with anti-inflammatory effects, historically used for conditions like gout and familial Mediterranean fever, and has shown promise in reducing cardiovascular events by targeting inflammation in blood vessel plaques.
Ertugliflozin for Pediatric Type 2 Diabetes
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial will study whether ertugliflozin is safe and effective in children with Type 2 Diabetes who are already taking metformin and/or insulin. The goal is to see if ertugliflozin can help lower HbA1C levels more than placebo after 24 weeks.
Trials With No Placebo
Insulin
Inhaled Insulin for Gestational Diabetes
Recruiting1 awardPhase 2 & 3
Santa Barbara, California
"This trial will study pregnant women with gestational diabetes to see how two different insulin treatments affect their blood sugar after meals. The women will come to the clinic for two meal sessions where they will use either
Online Intervention for Gestational Diabetes Postpartum Care
Recruiting1 award4 criteria
Oakland, California
This trial tests components of an online intervention to help women with GDM get postpartum screening and programs for diabetes prevention. It mixes standard health info with motivational and logistical help. It uses a randomized factorial study design.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.